Literature DB >> 1309459

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.

M Laga1, J P Icenogle, R Marsella, A T Manoka, N Nzila, R W Ryder, S H Vermund, W L Heyward, A Nelson, W C Reeves.   

Abstract

Certain human genital papillomaviruses (HPV) are strongly associated with cervical dysplasia and cancer. Evidence is accumulating that HPV infection and ano-genital cancers are more common in patients with the acquired immunodeficiency syndrome. The objective of our study was to evaluate the extent to which HPV infection and associated cervical disease constitute opportunistic complications of human immunodeficiency virus (HIV) infection in a population of sexually promiscuous, HIV-infected women in Kinshasa, Zaire. In 1989 we obtained Pap smears and cervicovaginal lavage specimens for HPV DNA testing from 47 HIV-seropositive and 48 HIV-seronegative prostitutes who were part of a cohort under observation since 1988. Thirty-eight percent of the HIV-seropositive and 8% of the seronegative women (odds ratio = 6.8; p = 0.001) had HPV DNA detected by either ViraType, a dot-blot assay which detects specific genital HPV types, or low-stringency Southern blot, which detects all HPV types. Eighty-two women (86%) had an interpretable Pap smear; 11 of 41 (27%) HIV-seropositive women and one of 41 (3%) seronegative women had cervical intra-epithelial neoplasia (CIN) (odds ratio = 14.7; p = 0.002). HIV seropositivity, HPV infection and CIN were highly associated. Eight (73%) of 11 seropositive women with CIN had HPV detected. Both HPV infection and cervical cancer may emerge as opportunistic complications of HIV infection in populations in which HIV, HPV and cervical cancer are common.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309459     DOI: 10.1002/ijc.2910500110

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.

Authors:  Groesbeck P Parham; Vikrant V Sahasrabuddhe; Mulindi H Mwanahamuntu; Bryan E Shepherd; Michael L Hicks; Elizabeth M Stringer; Sten H Vermund
Journal:  Gynecol Oncol       Date:  2006-07-27       Impact factor: 5.482

2.  The absence of adult mortality data for sub-Saharan Africa: a practical solution.

Authors:  J S Kaufman; M C Asuzu; C N Rotimi; O O Johnson; E E Owoaje; R S Cooper
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 3.  STD control in drug users and street youth.

Authors:  A van den Hoek
Journal:  Genitourin Med       Date:  1997-08

4.  Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer.

Authors:  Brooks L Rademacher; Kristina A Matkowskyj; Emily D LaCount; Evie H Carchman
Journal:  Eur J Cancer Prev       Date:  2019-11       Impact factor: 2.497

5.  HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners.

Authors:  S D Vernon; E R Unger; M A Piper; S T Severin; S Z Wiktor; P D Ghys; D L Miller; I R Horowitz; A E Greenberg; W C Reeves
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

6.  Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners.

Authors:  M A Piper; S T Severin; S Z Wiktor; E R Unger; P D Ghys; D L Miller; I R Horowitz; A E Greenberg; W C Reeves; S D Vernon
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

7.  Prevalence and incidence of cervical intra-epithelial neoplasia among female sex workers in Korogocho, Kenya.

Authors:  S K Njagi; N R Mugo; A J Reid; S Satyanarayana; K Tayler-Smith; W Kizito; J Kwatampora; W Waweru; J Kimani; J S Smith
Journal:  Public Health Action       Date:  2013-12-21

8.  The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania.

Authors:  P Mayaud; D K Gill; H A Weiss; E Uledi; L Kopwe; J Todd; G ka-Gina; H Grosskurth; R J Hayes; D C Mabey; C J Lacey
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 9.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

10.  Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types.

Authors:  O Martin Williams; Keith W Hart; Eddie C Y Wang; Colin M Gelder
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.